CR6797A - Inhibidor del intercambiador de sodio-hidrogeno de tipo 1(nhe-1) - Google Patents

Inhibidor del intercambiador de sodio-hidrogeno de tipo 1(nhe-1)

Info

Publication number
CR6797A
CR6797A CR6797A CR6797A CR6797A CR 6797 A CR6797 A CR 6797A CR 6797 A CR6797 A CR 6797A CR 6797 A CR6797 A CR 6797A CR 6797 A CR6797 A CR 6797A
Authority
CR
Costa Rica
Prior art keywords
nhe
inhibitor
sodium
type
hydrogen exchanger
Prior art date
Application number
CR6797A
Other languages
English (en)
Spanish (es)
Inventor
George Chen Weichao
David Cox Eric
Guzman Perez Angel
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of CR6797A publication Critical patent/CR6797A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Treatment Of Water By Ion Exchange (AREA)
  • Preventing Corrosion Or Incrustation Of Metals (AREA)
  • Plural Heterocyclic Compounds (AREA)
CR6797A 2000-04-28 2002-10-18 Inhibidor del intercambiador de sodio-hidrogeno de tipo 1(nhe-1) CR6797A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US20043200P 2000-04-28 2000-04-28

Publications (1)

Publication Number Publication Date
CR6797A true CR6797A (es) 2004-05-17

Family

ID=22741697

Family Applications (1)

Application Number Title Priority Date Filing Date
CR6797A CR6797A (es) 2000-04-28 2002-10-18 Inhibidor del intercambiador de sodio-hidrogeno de tipo 1(nhe-1)

Country Status (40)

Country Link
EP (1) EP1276737A1 (is)
JP (1) JP2003531900A (is)
KR (1) KR20020093079A (is)
CN (1) CN1225466C (is)
AP (1) AP2002002651A0 (is)
AR (1) AR028375A1 (is)
AU (1) AU2001235896A1 (is)
BG (1) BG107139A (is)
BR (1) BR0110268A (is)
CA (1) CA2407535A1 (is)
CO (1) CO5221125A1 (is)
CR (1) CR6797A (is)
CZ (1) CZ20023408A3 (is)
DZ (1) DZ3310A1 (is)
EA (1) EA004882B1 (is)
EE (1) EE200200615A (is)
GT (1) GT200100064A (is)
HN (1) HN2001000042A (is)
HR (1) HRP20020851A2 (is)
HU (1) HUP0300651A2 (is)
IL (1) IL152075A0 (is)
IS (2) IS6567A (is)
MA (1) MA26897A1 (is)
MX (1) MXPA02010600A (is)
MY (1) MY133842A (is)
NO (1) NO20025132L (is)
NZ (1) NZ521348A (is)
OA (1) OA12256A (is)
PA (1) PA8513301A1 (is)
PE (1) PE20011270A1 (is)
PL (1) PL357765A1 (is)
SK (1) SK14872002A3 (is)
SV (1) SV2002000418A (is)
TN (1) TNSN01065A1 (is)
TR (1) TR200202439T2 (is)
UA (1) UA73348C2 (is)
UY (1) UY26680A1 (is)
WO (1) WO2001083470A1 (is)
YU (1) YU79602A (is)
ZA (1) ZA200208605B (is)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2436539A1 (en) * 2001-01-31 2002-08-08 Pfizer Products Inc. Ethanolates of sodium-hydrogen exchanger type-1 inhibitor
MXPA04004685A (es) * 2001-12-19 2004-08-12 Pfizer Prod Inc Procedimientos para preparar inhibidores de tipo-1 de intercambiador sodio-hidrogeno.
EP1499317A1 (en) * 2002-05-02 2005-01-26 Pfizer Products Inc. Treatment of diabetes and diabetic complications with nhe-1 inhibitors
FR2840302B1 (fr) * 2002-06-03 2004-07-16 Aventis Pharma Sa Derives d'isoindolones, procede de preparation et intermediaire de ce procede a titre de medicaments et compositions pharmaceutiques les renfermant
ES2220185B1 (es) * 2002-07-16 2006-04-01 Consejo Sup. De Investig. Cientificas Nuevo peptido inhibidor del intercambiador na+/h+ (pinhe), y sus aplicaciones.
CA2515939A1 (en) * 2003-02-14 2004-09-02 Smithkline Beecham Corporation Novel compounds
RU2518741C1 (ru) * 2013-03-22 2014-06-10 Федеральное государственное автономное образовательное учреждение высшего профессионального образования "ЮЖНЫЙ ФЕДЕРАЛЬНЫЙ УНИВЕРСИТЕТ" СРЕДСТВО, ИНГИБИРУЮЩЕЕ Na+/H+-ОБМЕН, И ГАЛОГЕНИДЫ 1-ДИАЛКИЛАМИНОЭТИЛ-3-[ЗАМЕЩЕННЫЙ(ДИЗАМЕЩЕННЫЙ) ФЕНАЦИЛ]-2-АМИНОБЕНЗИМИДАЗОЛИЯ

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002504546A (ja) * 1998-02-27 2002-02-12 ファイザー・プロダクツ・インク 虚血の治療のためのｎ−［（置換５員ジもしくはトリアザ二不飽和環）カルボニル］グアニジン誘導体

Also Published As

Publication number Publication date
ZA200208605B (en) 2003-10-24
UY26680A1 (es) 2001-12-28
HRP20020851A2 (en) 2005-02-28
MXPA02010600A (es) 2003-03-10
CN1426404A (zh) 2003-06-25
GT200100064A (es) 2002-03-22
HN2001000042A (es) 2001-07-09
MA26897A1 (fr) 2004-12-20
YU79602A (en) 2006-05-25
EP1276737A1 (en) 2003-01-22
CO5221125A1 (es) 2002-11-28
IL152075A0 (en) 2003-05-29
BG107139A (bg) 2003-07-31
WO2001083470A1 (en) 2001-11-08
JP2003531900A (ja) 2003-10-28
MY133842A (en) 2007-11-30
NZ521348A (en) 2004-09-24
UA73348C2 (en) 2005-07-15
IS6588A (is) 2002-10-21
TR200202439T2 (tr) 2003-02-21
BR0110268A (pt) 2003-12-30
EE200200615A (et) 2004-04-15
PL357765A1 (en) 2004-07-26
SV2002000418A (es) 2002-07-03
AR028375A1 (es) 2003-05-07
AU2001235896A1 (en) 2001-11-12
PE20011270A1 (es) 2001-12-12
PA8513301A1 (es) 2003-09-05
NO20025132L (no) 2002-12-12
OA12256A (en) 2003-11-06
AP2002002651A0 (en) 2002-12-31
CA2407535A1 (en) 2001-11-08
CZ20023408A3 (cs) 2004-01-14
CN1225466C (zh) 2005-11-02
DZ3310A1 (fr) 2001-11-07
KR20020093079A (ko) 2002-12-12
EA200201023A1 (ru) 2003-02-27
HUP0300651A2 (hu) 2003-07-28
SK14872002A3 (sk) 2004-03-02
NO20025132D0 (no) 2002-10-25
TNSN01065A1 (fr) 2005-11-10
IS6567A (is) 2002-09-24
EA004882B1 (ru) 2004-08-26

Similar Documents

Publication Publication Date Title
GT199900022A (es) Compuestos para el tratamiento de la isquemia
GT199900150A (es) 1,2,3,4-tetrahidroquinolinas 2-sustituidas 4-carboxiamino sustituidas.
ES2196630T3 (es) Isotiazolcarboxiamidas y su empleo para la proteccion de las plantas.
ES2145638T3 (es) Nuevos compuestos azoicos, utilizacion para tincion, composiciones que los contienen y procedimientos de tincion.
ES2157027T3 (es) Oxazolidinonas sustituidas y su uso como farmacos antibacterianos.
ECSP055747A (es) Antagonistas de cgrp elegidos, procedimiento para su preparación, así como su empleo como medicamentos
AR029737A1 (es) Concentrados de anticongelantes a base de amidas y composiciones refrigerantes que los comprenden, para la proteccion del magnesio y aleaciones de magnesio
ES2100907T3 (es) Bencimidazoles, medicamentos que contienen estos compuestos y proced imiento para su preparacion.
ES2175161T3 (es) Derivados de piperazina como antagonistas de taquiquinina.
MX9307232A (es) Arilcicloalquilaminas n,n-disustituidas, sus sales, medicamentos que contiene estos compuestos y su empleo, asi como procedimientos para su preparacion.
PA8586801A1 (es) Inhibidores de hiv-integrasa, composiciones farmaceuticas y metodos para su uso
AR005431A1 (es) Ozocolorantes reactivos con componentes de copulacion de la serie de los acidos aminonaftalensulfonicos, naftilaminas utilizadas y productos intermediosformados, en la preparacion de dichos ozocolorantes y utilizacion de los ozocolorantes.
UY27203A1 (es) Bencimidazoles útiles en el tratamiento de la disfunción sexual
AR020563A1 (es) Compuestos (poli)tia-alquinoicos y sus derivados, composiciones que los incluyen y su utilizacion
AR030537A1 (es) Acidos quinolincarboxilicos y naftiridincarboxilico antibacterianos
PA8513301A1 (es) Inhibidor del intercambiador de sodio-hidrògeno de tipo 1
ES2135722T3 (es) 1,5-benzodiacepinas 5-heterociclicas moduladoras de la cck o de la gastrina.
GT199900113A (es) Inhibidores de las fkbp.
MX9300306A (es) Bencimidazoles medicamentos que contienen estos compuestos y procedimiento para su preparacion.
MX9306178A (es) Bencimidazoles medicamentos que contienen estos compuestos yprocedimientos para su preparacion.
ES2164151T3 (es) N-(indol-2-carbonil)glicinamidas sustituidas y derivados como inhibidores de la glucogeno fosforilasa.
AR006675A1 (es) 4-benzoilisotiazoles herbicidas, procedimiento para obtenerlas, las composiciones herbicidas que las contienen y el procedimiento de aplicacionde dichos compuestos.
ES2175661T3 (es) Derivados de la isoflavona, procedimientos para la preparacion de los mismos y composiciones farmaceuticas que los contienen.
SV2002000209A (es) Cristales de inhibidor del intercambiador de sodio- hidrogeno tipo 1 ref. pc10730aado/bb
UY26417A1 (es) Cristales de inhibidor del intercambiador de sodio-hidrógeno tipo 1

Legal Events

Date Code Title Description
FA Abandonment or withdrawal (granting procedure)